<?xml version="1.0" encoding="UTF-8"?>
<ref id="B158-pharmaceuticals-12-00157">
 <label>158.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Cederquist</surname>
    <given-names>G.Y.</given-names>
   </name>
   <name>
    <surname>Fan</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hartley</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Mukherjee</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Tomishima</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brennand</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Schwartz</surname>
    <given-names>R.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>High-content screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus infection in fetal-like organoids and adult brain</article-title>
  <source>Cell Stem Cell</source>
  <year>2017</year>
  <volume>21</volume>
  <fpage>274</fpage>
  <lpage>283</lpage>
  <pub-id pub-id-type="doi">10.1016/j.stem.2017.06.017</pub-id>
  <?supplied-pmid 28736217?>
  <pub-id pub-id-type="pmid">28736217</pub-id>
 </element-citation>
</ref>
